Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 7, 2012

 

 

Streamline Health Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-28132   31-1455414

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

10200 Alliance Road, Suite 200, Cincinnati, OH   45242-4716
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (513) 794-7100

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On June 7, 2012, Streamline Health Solutions, Inc. (“Streamline Health”) issued the press release attached hereto as Exhibit 99.1, which press release contains financial information about Streamline Health’s first fiscal quarter ended April 30, 2012. The information hereunder shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

 

EXHIBIT
NUMBER
   DESCRIPTION
99.1    First Quarter Earnings News Release of Streamline Health Solutions, Inc. dated June 7, 2012.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Streamline Health Solutions, Inc.
Date: June 7, 2012     By:  

/s/ Stephen H. Murdock

      Stephen H. Murdock
      Chief Financial Officer

 

3


INDEX TO EXHIBITS

 

Exhibit No.

  

Description of Exhibit

99.1    First Quarter Earnings News Release of Streamline Health Solutions, Inc. dated June 7, 2012.

 

4

First Quarter Earnings News Release

Exhibit 99.1

 

LOGO

News Release

Visit our web site at: www.streamlinehealth.net

 

COMPANY CONTACT:      INVESTOR CONTACT:
Robert E. Watson      John Baldissera
Chief Executive Officer      BPC Financial Marketing
(513) 794-7100      (800) 368-1217

STREAMLINE HEALTH® SOLUTIONS REPORTS Q1 RESULTS

Cincinnati, Ohio — June 7, 2012 — Streamline Health Solutions, Inc. (Nasdaq: STRM) today announced financial results for the first quarter of fiscal year 2012, ended April 30, 2012.

Highlights for the quarter included:

 

   

Achieved net profit of $492,000;

 

   

Adjusted EBITDA for first quarter 2012 was $1.7 million an increase of 172% over first quarter 2011;

 

   

Recurring maintenance revenues improved by 13% over the prior comparable quarter;

 

   

Software as a service (SaaS) revenues for the quarter increased 22% over the prior comparable quarter, excluding $490,000 of incremental SaaS revenue from the acquired operations of Interpoint Partners;

 

   

New sales bookings for the quarter were $4.4 million;

 

   

Maintenance and SaaS contract renewals for the quarter were $3.1 million;

 

   

Backlog at the end of the quarter was $31.4 million, which was a 78% increase from the first quarter of 2011;

Revenues for the three month period ended April 30, 2012, were $5,445,000; as compared to $4,140,000 in the comparable period of fiscal 2011. The quarterly and year to date increase was primarily attributable to revenues provided by increases in recurring maintenance and SaaS revenues.

The former Interpoint Partners, LLC business, acquired in the fourth quarter of fiscal 2011, contributed an incremental $490,000 in SaaS revenue in the first quarter of fiscal 2012. Recurring revenues from SaaS (net of Interpoint incremental revenues) and maintenance increased $203,000 and $275,000, respectively. These increases are due to annual increases, expansion of services to current clients, and additional revenue from a client that has transitioned to a direct relationship with Streamline Health.


Operating expenses for the three-month period ending April 30, 2012 were $4,773,000, compared to $4,394,000 in the comparable prior year period; an increase of $379,000 or 9% over the prior year comparable period.

As a result, Streamline Health recorded an operating profit of $672,000 or $0.07 per fully diluted share, for the three month period ended April 30, 2012 compared with an operating loss of $254,000, or ($0.03) per fully diluted share, for the prior year comparable quarter. Adjusted EBITDA* (a non-GAAP measure) for the quarter ended April 30, 2012 was $1.7 million, or $0.17 per fully diluted common share, compared to $630,000, or $0.06 per fully diluted common share in the comparable prior year quarter. A reconciliation table is provided below.

New sales bookings for the fourth quarter were $4.4 million, primarily consisting of professional services, and software as a service contracts. Maintenance and SaaS renewals or extensions were $3.1 million.

Backlog at April 30, 2012 was $31.4 million, compared with $27.4 million at January 31, 2012 and $17.7 million at April 30, 2011. The increase in the current backlog reflects significant new SaaS contract signings as well as current clients purchasing additional solutions. Additions to backlog included a five year agreement with Boston Medical Center to extend the use of our business analytics and patient financial services solutions, a renewal for a new five year agreement with Bronx-Lebanon Hospital Center, which was also transitioned to a direct agreement with Streamline Health; and a new SaaS agreement with Einstein Healthcare Network to employ our OpportunityAnyWare, ARWare, and 835 DenialWare solutions.

Robert E. Watson, President and Chief Executive Officer of Streamline Health said, “The results for the quarter, by every financial metric, clearly highlight that we are making meaningful progress in our transition to a results oriented healthcare information technology company. Needless to say, we are pleased with our progress. This quarter was a significant step forward in the transition process that began some fifteen months ago.”

Mr. Watson continued, “Continuing the trend noted in previous quarters, we are also pleased with the transition, completed during the quarter, of Bronx-Lebanon Hospital Center to a ‘direct client’ and the extension of their agreement with us for an additional five years. Also during the quarter, Einstein Healthcare Network, a ten-year client of our AccessAnyWare solution, purchased our OpportunityAnyWare solution for their clinic operations. This was the first purchase of the former Interpoint Partners’ solution by a Streamline Health client. Additionally, the purchase by Boston Medical Center of the OpportunityAnyWare solution for their clinics is an example of our team’s ability to upsell additional solutions in our installed base of clients. In conjunction with our continuing focus on managing operating expenses, we continue to make meaningful progress in our goal for Streamline Health to become a world-class healthcare information technology company.”

 

* Non-GAAP Financial Measures

 

2


Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States (“GAAP”). Streamline Health’s management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health’s management believes that these measures provide useful supplemental information regarding the performance of Streamline Health’s business operations.

Streamline Health defines “adjusted EBITDA” as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, and stock-based compensation expense. A table illustrating this measure is included in this publication.

Conference Call Information

Streamline Health will conduct a conference call and webcast to review the results of the first quarter of fiscal 2012 today, June 7, 2012, at 11:00 a.m. ET.

Interested parties can access the call by dialing 877-407-8037, or listen via a live Internet webcast, which can be found at www.streamlinehealth.net or http://www.investorcalendar.com/IC/CEPage.asp?ID=168741.

In addition, a replay of the conference call will be archived and available until June 29, 2012 at the following number: 877-660-6853, account number: 396 and then conference ID: 395382.

About Streamline Health

Streamline Health provides solutions that help hospitals and physician groups improve efficiencies and business processes across the enterprise to enhance and protect revenues. Our enterprise content management solutions transform unstructured data into digital assets that seamlessly integrate with disparate clinical, administrative, and financial information systems. Our business analytics solutions provide real-time access to key performance metrics that enable healthcare organizations to identify and manage opportunities to maximize financial performance. Our integrated workflow systems automate and manage critical business activities to improve organizational accountability to drive both operational and financial performance. Across the revenue cycle, our solutions offer a flexible, customizable way to optimize the clinical and financial performance of any healthcare organization. For more information visit www.streamlinehealth.net.

 

3


Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell Streamline Health products, the ability of Streamline Health to control costs, availability of products produced from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which Streamline Health operates and nationally, and Streamline Health’s ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management‘s analysis only as of the date hereof. Streamline Health undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Financial Tables on Following Pages

 

4


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

     Three Months ended April 30,  
     2012     2011  

Revenues:

    

Systems sales

   $ 353,530      $ 131,002   

Professional services

     1,122,439        1,007,054   

Maintenance and support

     2,351,575        2,076,907   

Software as a service

     1,617,589        925,059   
  

 

 

   

 

 

 

Total revenues

     5,445,133        4,140,022   
  

 

 

   

 

 

 

Operating expenses:

    

Cost of systems sales

     686,528        540,952   

Cost of professional services

     552,482        736,543   

Cost of maintenance and support

     725,281        597,328   

Cost of software as a service

     682,306        436,423   

Selling, general and administrative

     1,669,760        1,664,661   

Product research and development

     456,363        417,774   
  

 

 

   

 

 

 

Total operating expenses

     4,772,720        4,393,681   
  

 

 

   

 

 

 

Operating income (loss)

     672,413        (253,659

Other income (expense):

    

Interest expense

     (207,830     (19,842

Miscellaneous income (expense)

     36,045        (4,955
  

 

 

   

 

 

 

Earnings (loss) before income taxes

     500,628        (278,456

Income tax expense

     (9,000     (2,315
  

 

 

   

 

 

 

Net earnings (loss)

   $ 491,628      $ (280,771
  

 

 

   

 

 

 

Basic net earnings (loss) per common share

   $ 0.05      $ (0.03
  

 

 

   

 

 

 

Number of shares used in basic per common share computation

     10,307,259        9,649,508   
  

 

 

   

 

 

 

Diluted net earnings (loss) per common share

   $ 0.05      $ (0.03
  

 

 

   

 

 

 

Number of shares used in diluted per common share computation

     10,307,259        9,649,508   
  

 

 

   

 

 

 

 

5


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Assets

 

     (Unaudited)
April 30, 2012
    (Audited)
January 31, 2012
 

Current assets:

    

Cash and cash equivalents

   $ 3,133,991      $ 2,243,054   

Accounts receivable, net of allowance for doubtful accounts of $100,000 and $100,000, respectively

     2,797,571        4,484,605   

Contract receivables

     376,150        430,370   

Prepaid hardware and third party software for future delivery

     22,777        38,193   

Prepaid client maintenance contracts

     1,027,142        788,917   

Prepaid and other assets

     564,523        256,104   

Deferred income taxes

     167,000        167,000   
  

 

 

   

 

 

 

Total current assets

     8,089,154        8,408,243   
  

 

 

   

 

 

 

Non-current assets:

    

Property and equipment:

    

Computer equipment

     3,110,035        2,892,885   

Computer software

     2,142,458        2,131,730   

Office furniture, fixtures and equipment

     756,375        756,375   

Leasehold improvements

     667,000        667,000   
  

 

 

   

 

 

 
     6,675,868        6,447,990   

Accumulated depreciation and amortization

     (5,411,873     (5,232,321
  

 

 

   

 

 

 

Property and equipment, net

     1,263,995        1,215,669   

Contract receivables, less current portion

     195,071        221,596   

Capitalized software development costs, net of accumulated amortization of $15,447,914 and $14,805,236, respectively

     9,694,496        9,830,175   

Intangible assets, net

     414,166        417,666   

Deferred financing cost, net

     126,169        145,857   

Goodwill

     4,060,504        4,060,504   

Other, including deferred income taxes of $711,000, respectively

     796,149        841,348   
  

 

 

   

 

 

 

Total non-current assets

     16,550,550        16,732,815   
  

 

 

   

 

 

 
   $ 24,639,704      $ 25,141,058   
  

 

 

   

 

 

 

 

6


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Liabilities and Stockholders’ Equity

 

     (Unaudited)
April 30, 2012
    (Audited)
January 31, 2012
 

Current liabilities:

    

Accounts payable

   $ 1,033,137      $ 879,027   

Accrued compensation

     746,845        887,130   

Accrued other expenses

     419,670        479,526   

Current portion of deferred revenues

     5,374,246        6,496,938   
  

 

 

   

 

 

 

Total current liabilities

     7,573,898        8,742,621   
  

 

 

   

 

 

 

Non-current liabilities:

    

Term loan

     4,120,000        4,120,000   

Convertible note

     3,000,000        3,000,000   

Contingent consideration for earn-out

     1,232,720        1,232,720   

Lease incentive liability, less current portion

     44,611        47,193   
  

 

 

   

 

 

 

Total non-current liabilities

     8,397,331        8,399,913   
  

 

 

   

 

 

 

Total liabilities

     15,971,229        17,142,534   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Convertible redeemable preferred stock, $.01 par value per share, 5,000,000 shares authorized, no shares issued

     —          —     

Common stock, $.01 par value per share, 25,000,000 shares authorized, and 10,433,716 shares issued and outstanding, respectively

     104,338        104,338   

Additional paid in capital

     38,539,303        38,360,980   

Accumulated deficit

     (29,975,166     (30,466,794
  

 

 

   

 

 

 

Total stockholders’ equity

     8,668,475        7,998,524   
  

 

 

   

 

 

 
   $ 24,639,704      $ 25,141,058   
  

 

 

   

 

 

 

 

7


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months Ended April 30,

(Unaudited)

 

     2012     2011  

Operating activities:

    

Net earnings (loss)

   $ 491,628      $ (280,771

Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:

    

Depreciation and amortization

     845,419        691,345   

Loss on disposal of equipment

     —          26,666   

Stock-based compensation expense

     178,323        196,967   

Change in assets and liabilities:

    

Accounts, contract and installment receivables

     1,767,779        1,042,191   

Other assets

     (486,029     (209,070

Accounts payable

     154,110        26,388   

Accrued expenses

     (202,723     (857,965

Deferred revenues

     (1,122,692     (863,964
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     1,625,815        (228,213
  

 

 

   

 

 

 

Investing activities:

    

Purchases of property and equipment

     (227,878     (157,681

Capitalization of software development costs

     (507,000     (785,000
  

 

 

   

 

 

 

Net cash used in investing activities

     (734,878     (942,681
  

 

 

   

 

 

 

Financing activities:

    

Net change under revolving credit facility

     —          300,000   

Payments on capital lease obligation

     —          (51,338
  

 

 

   

 

 

 

Net cash provided by financing activities

     —          248,662   
  

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents

     890,937        (922,232

Cash and cash equivalents at beginning of period

     2,243,054        1,403,949   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 3,133,991      $ 481,717   
  

 

 

   

 

 

 

Supplemental cash flow disclosures:

    

Interest paid

   $ 127,946      $ 16,841   
  

 

 

   

 

 

 

Income taxes paid

   $ 6,920      $ 11,897   
  

 

 

   

 

 

 

 

8


STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A

Backlog

 

     April 30, 2012      January 31, 2012      April 30, 2011  

Streamline Health proprietary software

   $ 94,000       $ 181,000       $ 111,000   

Hardware and third party software

     140,000         194,000         107,000   

Professional services

     5,240,000         5,945,000         4,729,000   

Maintenance and support

     10,973,000         10,542,000         6,550,000   

Software as a service

     15,000,000         10,504,000         6,199,000   
  

 

 

    

 

 

    

 

 

 

Total

   $ 31,447,000       $ 27,366,000       $ 17,696,000   
  

 

 

    

 

 

    

 

 

 

 

9


STREAMLINE HEALTH SOLUTIONS, INC.

Bookings

(Unaudited)

Table B

New bookings

 

     Three Months Ended  
     April 30, 2012  
     Value      % of Total Bookings  

Streamline Health Software licenses

   $ 50,000         1

Software as a service

     3,018,000         69

Maintenance and support

     62,000         1

Professional services

     958,000         22

Hardware & third party software

     307,000         7
  

 

 

    

 

 

 

Total bookings

   $ 4,395,000         100
  

 

 

    

 

 

 

 

10


STREAMLINE HEALTH SOLUTIONS, INC.

Reconciliation of Non-GAAP Financial Measures

(Unaudited)

Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health’s management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, Streamline Health believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company’s current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company’s management compensates for these limitations by considering the company’s financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release.

 

11


Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)

 

Adjusted EBITDA Reconciliation    Three Months Ended,  
     April 30,
2012
     April 30,
2011
 

Net earnings (loss)

   $ 492       $ (281

Interest expense

     208         20   

Income tax expense

     9         2   

Depreciation

     180         198   

Amortization of capitalized software development costs

     643         494   

Amortization of intangible assets

     3         —     
  

 

 

    

 

 

 

EBITDA

     1,535         433   
  

 

 

    

 

 

 

Stock-based compensation expense

     178         197   
  

 

 

    

 

 

 

Adjusted EBITDA

   $ 1,713       $ 630   
  

 

 

    

 

 

 

Adjusted EBITDA per diluted share

     

Earnings (loss) per share—diluted

   $ 0.05       $ (0.03
  

 

 

    

 

 

 

Adjusted EBITDA per adjusted diluted share

   $ 0.17       $ 0.06   
  

 

 

    

 

 

 

Diluted weighted average shares

     10,307,259         9,649,508   

Includable incremental shares—adjusted EBITDA (1)

     —           8,108   
  

 

 

    

 

 

 

Adjusted diluted shares

     10,307,259         9,657,616   
  

 

 

    

 

 

 

 

(1) The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed. If negative adjusted EBITDA is incurred, no additional incremental shares are assumed for adjusted diluted shares.

 

12